Analysts’ Viewpoint
Rise in demand for minimally invasive surgical procedures and increase in prevalence of cardiovascular diseases are key factors driving the global percutaneous transluminal angioplasty balloons market size. Percutaneous transluminal angioplasty procedure is a widely accepted treatment for patients suffering from cardiovascular diseases.
North America is a prominent market for percutaneous transluminal angioplasty balloons due to the surge in healthcare expenditure in the region. Key players are offering a variety of products to cater to the growth in preference for effective minimally invasive procedures. R&D in safety and efficacy of percutaneous transluminal angioplasty is likely to offer lucrative opportunities for market players.
Percutaneous Transluminal Angioplasty (PTA) is a minimally invasive medical procedure used for the treatment of various cardiovascular diseases such as atherosclerosis, peripheral artery disease, and coronary artery disease. PTA balloons are employed to widen or dilate narrowed or blocked blood vessels, thus allowing for better blood flow.
PTA is a widely accepted treatment for cardiovascular diseases, as it offers several advantages over traditional surgical procedures. It is minimally invasive, as it involves small incisions and usually does not require general anesthesia. This reduces the risk of complications and allows for a faster recovery time. Additionally, PTA is often performed as an outpatient procedure, which is more convenient for patients and can help reduce healthcare costs.
PTA balloons are available in various sizes and types. They are typically made of polyethylene terephthalate (PET) and are designed to be inflated to a specific pressure. When inflated, the balloon expands the narrowed or blocked blood vessel, thus allowing for better blood flow.
PTA balloons have been in use for many years. Recent advances in technology have led to the development of new and innovative products that offer improved performance and ease of use. These advancements have resulted in growth in adoption of PTA balloons for the treatment of cardiovascular diseases (CVDs).
CVD is a significant global health issue and one of the leading causes of death worldwide. The prevalence of CVD is increasing due to factors such as aging population, unhealthy lifestyle, and surge in cases of obesity and diabetes.
According to the World Health Organization (WHO), CVD is the leading cause of death globally, accounting for around 17.9 million deaths in 2019. As per the Centers for Disease Control and Prevention (CDC), CVD is responsible for one in every four deaths in the U.S. Thus, surge in incidence of CVDs is projected to spur percutaneous transluminal angioplasty balloons market growth in the near future.
Advancements in PTA balloon technology, such as drug-coated balloons and scoring balloons, have further increased its efficacy and safety, making it a popular minimally invasive treatment option among healthcare providers and patients.
Patients prefer minimally invasive procedures due to reduced hospital stay, faster recovery time, and lower risk of complications. Additionally, patients can return to their daily activities sooner, which reduces the disruption caused by PTA.
Advanced PTA balloons offer improved performance and are easy to use. These balloons are designed to be more precise and durable, which helps improve patient outcomes and reduce procedure time. Hence, R&D of new and improved PTA balloons is boosting market development.
According to the latest percutaneous transluminal angioplasty balloons market analysis, the conventional balloons product segment is expected to dominate the global landscape from 2023 to 2031. Conventional balloons are the most commonly used PTA balloons. These balloons are non-coated and have no drug-eluting or cutting capabilities. This makes them a cost-effective and widely available option for the treatment of cardiovascular diseases.
Conventional balloons are easy to use and can be quickly inflated and deflated, thus allowing for precise control during PTA. These balloons are available in a range of sizes, from 1 mm to over 30 mm. This makes them compatible with a variety of blood vessels. Conventional balloons also have a well-established safety record, as they are associated with a low rate of complications. Therefore, they are a preferred choice for healthcare providers.
Conventional PTA balloons can also be used in combination with other devices, such as stents, to further improve blood flow and reduce the risk of restenosis (re-narrowing of the blood vessel). This makes them a versatile treatment option for a range of cardiovascular diseases, including atherosclerosis, coronary artery disease, and peripheral artery disease.
According to the latest percutaneous transluminal angioplasty balloons market trends, the 0.014 inch guidewire compatibility segment is projected to account for the largest share during the forecast period. 0.014” guidewire facilitates navigation through narrow and tortuous blood vessels. It provides access to smaller blood vessels, allowing for a wider range of treatment options. 0.014” guidewire is particularly useful for the treatment of peripheral artery disease and coronary artery disease, where the blood vessels are often narrow and winding.
0.014” guidewire is highly maneuverable, which allows for precise control during PTA. It is highly flexible and can be navigated through tight spaces and around bends, thus reducing the risk of damage to the blood vessels. These advantages make the 0.014” guidewire a popular choice for healthcare providers who require a high degree of precision during various procedures.
0.014” guidewire is compatible with a wide range of PTA balloon catheters. This enables healthcare providers to select from a variety of balloons and tailor the treatment to the patient's specific needs. The flexibility allows for more personalized treatment plans, which can improve patient outcomes.
According to the latest percutaneous transluminal angioplasty balloons market research, the coronary angioplasty segment is expected to dominate the market from 2023 to 2031. Coronary angioplasty is commonly used for the treatment of coronary artery disease, a condition where the blood vessels that supply the heart with oxygen and nutrients become narrowed or blocked.
Coronary angioplasty is a minimally invasive procedure, as it involves only a small incision or puncture in the skin. This reduces recovery time and risk of complications such as bleeding, infection, and scarring. Coronary angioplasty has a high success rate.
The hospitals end-user segment accounted for the largest share during the forecast period. Hospitals offer a wide range of healthcare services, including PTA. These healthcare settings have the necessary infrastructure and equipment, such as advanced imaging technologies and trained healthcare professionals, to perform complex procedures.
Thus, they are often the first choice for patients and healthcare providers for cardiovascular treatments.
According to the latest percutaneous transluminal angioplasty balloons market forecast, North America is estimated to dominate the industry from 2023 to 2031. Rise in prevalence of cardiovascular diseases and presence of advanced healthcare infrastructure are driving market expansion in the region.
The U.S. is a major growth engine of the industry in North America due to the presence of leading manufacturers and increase in investment in R&D of new products. Surge in healthcare expenditure and growth in adoption of minimally invasive procedures are also fueling the demand for PTA balloons in North America.
The market in Asia Pacific is expected to grow at the fastest rate during the forecast period. Rise in geriatric population, increase in investment in healthcare infrastructure, and high prevalence of cardiovascular diseases are boosting market dynamics of the region.
The global percutaneous transluminal angioplasty balloons market report profiles key vendors based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
Abbott, B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, Cordis, Medtronic, MicroPort Scientific Corporation, Opto Circuits (India) Ltd., Spectranetics (Philips Healthcare), and Terumo Corporation are prominent entities operating in the market.
Manufacturers are investing substantially in R&D of robust PTA balloons to increase their percutaneous transluminal angioplasty balloons market share. They are utilizing advanced materials and innovative designs to improve the performance and usability of their products. Some PTA balloons now have hydrophilic coatings, which ease their navigation through blood vessels. Additionally, some balloons are now designed to be compatible with smaller access sheaths, thus reducing the size of the incision needed for PTA.
|
Attribute |
Detail |
|
Market Size Value in 2022 |
US$ 2.1 Bn |
|
Market Forecast Value in 2031 |
More than US$ 3.5 Bn |
|
Compound Annual Growth Rate (CAGR) |
5.4% |
|
Forecast Period |
2023–2031 |
|
Historical Data Available for |
2017–2022 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
It was valued at US$ 2.1 Bn in 2022
It is projected to reach more than US$ 3.5 Bn by the end of 2031
The CAGR is anticipated to be 5.4% from 2023 to 2031
Increase in prevalence of cardiovascular diseases and rise in preference for minimally invasive procedures
The conventional balloons product segment held the largest share in 2022
North America is expected to account for the largest share from 2023 to 2031
Abbott, B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, Cordis, Medtronic, MicroPort Scientific Corporation, Opto Circuits (India) Ltd., Spectranetics (Philips Healthcare), and Terumo Corporation
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Percutaneous Transluminal Angioplasty Balloons Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Percutaneous Transluminal Angioplasty Balloons Market Analysis and Forecast, 2017 – 2031
5. Key Insights
5.1. Technological Advancement
5.2. Pipeline Analysis
5.3. Disease Incidence and Prevalence
5.4. Regulatory Scenario
5.5. COVID-19 Impact Analysis
6. Global Percutaneous Transluminal Angioplasty Balloons Market Analysis and Forecast, By Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast By Product, 2017 – 2031
6.3.1. Conventional Balloons
6.3.2. Drug-eluting Balloons
6.3.3. Cutting and Scoring Balloons
6.4. Market Attractiveness By Product
7. Global Percutaneous Transluminal Angioplasty Balloons Market Analysis and Forecast, By Guidewire Compatibility
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast By Guidewire Compatibility, 2017 – 2031
7.3.1. 0.014 Inch
7.3.2. 0.018 Inch
7.3.3. 0.035 Inch
7.4. Market Attractiveness By Guidewire Compatibility
8. Global Percutaneous Transluminal Angioplasty Balloons Market Analysis and Forecast, By Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast By Application, 2017 – 2031
8.3.1. Coronary Angioplasty
8.3.2. Peripheral Angioplasty
8.4. Market Attractiveness By Application
9. Global Percutaneous Transluminal Angioplasty Balloons Market Analysis and Forecast, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user, 2017 – 2031
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Specialty Clinics
9.4. Market Attractiveness By End-user
10. Global Percutaneous Transluminal Angioplasty Balloons Market Analysis and Forecast, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Percutaneous Transluminal Angioplasty Balloons Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product, 2017 – 2031
11.2.1. Conventional Balloons
11.2.2. Drug-eluting Balloons
11.2.3. Cutting and Scoring Balloons
11.3. Market Value Forecast By Guidewire Compatibility, 2017 – 2031
11.3.1. 0.014 Inch
11.3.2. 0.018 Inch
11.3.3. 0.035 Inch
11.4. Market Value Forecast By Application, 2017 – 2031
11.4.1. Coronary Angioplasty
11.4.2. Peripheral Angioplasty
11.5. Market Value Forecast By End-user, 2017 – 2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Specialty Clinics
11.6. Market Value Forecast By Country, 2017 – 2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Guidewire Compatibility
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Percutaneous Transluminal Angioplasty Balloons Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product, 2017 – 2031
12.2.1. Conventional Balloons
12.2.2. Drug-eluting Balloons
12.2.3. Cutting and Scoring Balloons
12.3. Market Value Forecast By Guidewire Compatibility, 2017 – 2031
12.3.1. 0.014 Inch
12.3.2. 0.018 Inch
12.3.3. 0.035 Inch
12.4. Market Value Forecast By Application, 2017 – 2031
12.4.1. Coronary Angioplasty
12.4.2. Peripheral Angioplasty
12.5. Market Value Forecast By End-user, 2017 – 2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Specialty Clinics
12.6. Market Value Forecast By Country, 2017 – 2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Guidewire Compatibility
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country
13. Asia Pacific Percutaneous Transluminal Angioplasty Balloons Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product, 2017 – 2031
13.2.1. Conventional Balloons
13.2.2. Drug-eluting Balloons
13.2.3. Cutting and Scoring Balloons
13.3. Market Value Forecast By Guidewire Compatibility, 2017 – 2031
13.3.1. 0.014 Inch
13.3.2. 0.018 Inch
13.3.3. 0.035 Inch
13.4. Market Value Forecast By Application, 2017 – 2031
13.4.1. Coronary Angioplasty
13.4.2. Peripheral Angioplasty
13.5. Market Value Forecast By End-user, 2017 – 2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Specialty Clinics
13.6. Market Value Forecast By Country, 2017 – 2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Guidewire Compatibility
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country
14. Latin America Percutaneous Transluminal Angioplasty Balloons Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product, 2017 – 2031
14.2.1. Conventional Balloons
14.2.2. Drug-eluting Balloons
14.2.3. Cutting and Scoring Balloons
14.3. Market Value Forecast By Guidewire Compatibility, 2017 – 2031
14.3.1. 0.014 Inch
14.3.2. 0.018 Inch
14.3.3. 0.035 Inch
14.4. Market Value Forecast By Application, 2017 – 2031
14.4.1. Coronary Angioplasty
14.4.2. Peripheral Angioplasty
14.5. Market Value Forecast By End-user, 2017 – 2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Specialty Clinics
14.6. Market Value Forecast By Country, 2017 – 2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Guidewire Compatibility
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country
15. Middle East & Africa Percutaneous Transluminal Angioplasty Balloons Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Product, 2017 - 2031
15.2.1. Conventional Balloons
15.2.2. Drug-eluting Balloons
15.2.3. Cutting and Scoring Balloons
15.3. Market Value Forecast By Guidewire Compatibility, 2017 - 2031
15.3.1. 0.014 Inch
15.3.2. 0.018 Inch
15.3.3. 0.035 Inch
15.4. Market Value Forecast By Application, 2017 - 2031
15.4.1. Coronary Angioplasty
15.4.2. Peripheral Angioplasty
15.5. Market Value Forecast By End-user, 2017 - 2031
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers
15.5.3. Specialty Clinics
15.6. Market Value Forecast By Country, 2017 - 2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Guidewire Compatibility
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country
16. Competition Landscape
16.1. Market Player – Competition Matrix (by Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2021)
16.3. Company Profiles
16.3.1. Abbott
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Indication Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. B. Braun Melsungen AG
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Indication Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Boston Scientific Corporation
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Indication Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Cook Medical
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Indication Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Cordis
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Indication Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.6. Medtronic
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Indication Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.7. MicroPort Scientific Corporation
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Indication Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.8. Opto Circuits (India) Ltd.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Indication Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.9. Terumo Corporation
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Indication Portfolio
16.3.9.3. Financial Overview
16.3.10. Spectranetics (Philips Healthcare)
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Indication Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
List of Tables
Table 01: Global Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Guidewire Compatibility, 2017–2031
Table 03: Global Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 04: Global Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 05: Global Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 08: North America Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Guidewire Compatibility, 2017–2031
Table 09: North America Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 10: North America Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 13: Europe Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Guidewire Compatibility, 2017–2031
Table 14: Europe Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 15: Europe Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 18: Asia Pacific Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Guidewire Compatibility, 2017–2031
Table 19: Asia Pacific Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Asia Pacific Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Latin America Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Latin America Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 23: Latin America Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Guidewire Compatibility, 2017–2031
Table 24: Latin America Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 25: Latin America Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 26: Middle East & Africa Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 27: Middle East & Africa Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 28: Middle East & Africa Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Guidewire Compatibility, 2017–2031
Table 29: Middle East & Africa Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 30: Middle East & Africa Percutaneous Transluminal Angioplasty Balloons Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Percutaneous Transluminal Angioplasty Balloons Market Value (US$ Mn) Forecast, 2023–2031
Figure 02: Global Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by Product (2022)
Figure 03: Global Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by Guidewire Compatibility (2022)
Figure 04: Global Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by Application (2022)
Figure 05: Global Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by End-user (2022)
Figure 06: Global Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by Region (2022)
Figure 07: Global Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by Product, 2022 and 2031
Figure 08: Global Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Product, 2023–2031
Figure 09: Global Percutaneous Transluminal Angioplasty Balloons Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Conventional Balloons, 2023–2031
Figure 10: Global Percutaneous Transluminal Angioplasty Balloons Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Drug-eluting Balloons, 2023–2031
Figure 11: Global Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by Guidewire Compatibility, 2022 and 2031
Figure 12: Global Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Guidewire Compatibility, 2023–2031
Figure 13: Global Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by Application, 2022 and 2031
Figure 14: Global Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Application, 2023–2031
Figure 15: Global Percutaneous Transluminal Angioplasty Balloons Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Coronary Angioplasty, 2023–2031
Figure 16: Global Percutaneous Transluminal Angioplasty Balloons Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Peripheral Angioplasty, 2023–2031
Figure 17: Global Percutaneous Transluminal Angioplasty Balloons Market Value Share Analysis (%), by End-user, 2022 and 2031
Figure 18: Global Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by End-user, 2023–2031
Figure 19: Global Percutaneous Transluminal Angioplasty Balloons Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2023–2031
Figure 20: Global Percutaneous Transluminal Angioplasty Balloons Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ambulatory Surgical Centers, 2023–2031
Figure 21: Global Percutaneous Transluminal Angioplasty Balloons Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Specialty Clinics, 2023–2031
Figure 22: Global Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by Region, 2022 and 2031
Figure 23: Global Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Region, 2023–2031
Figure 24: North America Percutaneous Transluminal Angioplasty Balloons Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023–2031
Figure 25: North America Percutaneous Transluminal Angioplasty Balloons Market Value Share, by Country, 2022 and 2031
Figure 26: North America Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Country, 2022-2031
Figure 27: North America Percutaneous Transluminal Angioplasty Balloons Market Value Share Analysis (%), by Product, 2022 and 2031
Figure 28: North America Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Product, 2023–2031
Figure 29: North America Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by Application, 2022 and 2031
Figure 30: North America Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Application, 2023–2031
Figure 31: North America Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by End-user, 2022 and 2031
Figure 32: North America Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by End-user, 2023–2031
Figure 33: Europe Percutaneous Transluminal Angioplasty Balloons Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023–2031
Figure 34: Europe Percutaneous Transluminal Angioplasty Balloons Market Value Share, by Country/Sub-region, 2022 and 2031
Figure 35: Europe Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 36: Europe Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by Product, 2022 and 2031
Figure 37: Europe Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Product, 2023–2031
Figure 38: Europe Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by Application, 2022 and 2031
Figure 39: Europe Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Application, 2023–2031
Figure 40: Europe Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by End-user, 2022 and 2031
Figure 41: Europe Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by End-user, 2023–2031
Figure 42: Asia Pacific Percutaneous Transluminal Angioplasty Balloons Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023–2031
Figure 43: Asia Pacific Percutaneous Transluminal Angioplasty Balloons Market Value Share, by Country/Sub-region, 2022 and 2031
Figure 44: Asia Pacific Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 45: Asia Pacific Percutaneous Transluminal Angioplasty Balloons Market Value Share Analysis (%), by Product, 2022 and 2031
Figure 46: Asia Pacific Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Product, 2023–2031
Figure 47: Asia Pacific Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by Application, 2022 and 2031
Figure 48: Asia Pacific Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Application, 2023–2031
Figure 49: Asia Pacific Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by End-user, 2022 and 2031
Figure 50: Asia Pacific Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by End-user, 2023–2031
Figure 51: Latin America Percutaneous Transluminal Angioplasty Balloons Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023–2031
Figure 52: Latin America Percutaneous Transluminal Angioplasty Balloons Market Value Share, by Country/Sub-region, 2022 and 2031
Figure 53: Latin America Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 54: Latin America Percutaneous Transluminal Angioplasty Balloons Market Value Share Analysis (%), by Product, 2022 and 2031
Figure 55: Latin America Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Product, 2023–2031
Figure 56: Latin America Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by Application, 2022 and 2031
Figure 57: Latin America Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Application, 2023–2031
Figure 58: Latin America Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by End-user, 2022 and 2031
Figure 59: Latin America Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by End-user, 2023–2031
Figure 60: Middle East & Africa Percutaneous Transluminal Angioplasty Balloons Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023–2031
Figure 61: Middle East & Africa Percutaneous Transluminal Angioplasty Balloons Market Value Share, by Country/Sub-region, 2022 and 2031
Figure 62: Middle East & Africa Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 63: Middle East & Africa Percutaneous Transluminal Angioplasty Balloons Market Value Share Analysis (%), by Product, 2022 and 2031
Figure 64: Middle East & Africa Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Product, 2023–2031
Figure 65: Middle East & Africa Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by Application, 2022 and 2031
Figure 66: Middle East & Africa Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by Application, 2023–2031
Figure 67: Middle East & Africa Percutaneous Transluminal Angioplasty Balloons Market Value Share (%), by End-user, 2022 and 2031
Figure 68: Middle East & Africa Percutaneous Transluminal Angioplasty Balloons Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Percutaneous Transluminal Angioplasty Balloons Market
*86 figures and 60 tables includes